ZTS

Stock Details

ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 164.85$. Average daily volumn in 3 months 1.68M. Market cap 69.42B

Stock symbol : ZTS. Exchange : NYSE. Currency : USD
Lastest price : 148.29$. Total volume : 2.31M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Zoetis Inc. (ZTS)

Last Price

148.29$

Change

-2.66

Volume

2.31M


Previous Close	150.95
Open	150.42
Day Range	148.04-152.03
Bid	146.00 x 800
Ask	148.82 x 800
Volume	2.31M
Average Volume	1.68M


Market Cap	69.42B
Beta	0.76
52 Week Range	147.77-249.27
Trailing P/E	33.63
Foward P/E	26.43
Dividend (Yield %)	0.88%
Ex-Dividend Date	2022-07-20

Financial Details

According to Zoetis Inc.'s financial reports the company's revenue in 2021 were 7.78B an increase( +16.67%) over the years 2020 revenue that were of 6.67B. In 2021 the company's total earnings were 2.04B while total earnings in 2020 were 1.64B( +100%).

Loading ...

Organization

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or ... induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Market Cap:

69.42B

Revenue:

7.78B

Total Assets:

13.9B

Total Cash:

3.48B

News about "Zoetis Inc."

Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products

Source from : YAHOO!Finance - 2 days ago

PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia, September 30, 2022--Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company ...See details»

MAI Capital Management Decreases Stock Position in Zoetis Inc. (NYSE:ZTS)

Source from : Defense World - 1 days ago

MAI Capital Management decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS – Get Rating) by 38.1% during the second quarter, according to the company in its most recent disclosure with the SEC.See details»

Insiders at Zoetis Inc. (NYSE:ZTS) sold US$4.0m worth of stock, possibly indicating weakness in the future

Source from : Yahoo Finance - 7 hours ago

Many Zoetis Inc. (NYSE:ZTS) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether insiders are ...See details»

Zoetis Inc. (NYSE:ZTS) Shares Acquired by Sawtooth Solutions LLC

Source from : Defense World - 2 days ago

Sawtooth Solutions LLC raised its position in shares of Zoetis Inc. (NYSE:ZTS – Get Rating) by 15.5% in the second quarter, according to its most recent Form 13F filing with the Securities and ...See details»

The Price Is Right For Zoetis Inc. (NYSE:ZTS)

Source from : Yahoo - 8 days ago

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 13x, you may consider Zoetis Inc. (NYSE:ZTS) as a stock to avoid entirely with its 33.6x P/E ...See details»

Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results

Source from : Daily Herald - 3 days ago

Investors and the public may access the live webcast by visiting the Zoetis website at Information on accessing and pre-registering for the webcast is available beginning today. A replay of the ...See details»

Boasting A 46% Return On Equity, Is Zoetis Inc. (NYSE:ZTS) A Top Quality Stock?

Source from : Yahoo News - 12 days ago

This article is for those who would like to learn about Return On Equity (ROE). To keep the lesson grounded in practicality, we'll use ROE to better understand Zoetis Inc. (NYSE:ZTS). Return on equity ...See details»

Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount

Source from : Daily Herald - 12 days ago

Seramount (formerly Working Mother Media) recognized Zoetis for forward-thinking programs and benefits related to parental leave, family support, wellness offerings and job flexibility A.J. Edge and ...See details»

Oversold Conditions For Zoetis (ZTS)

Source from : Nasdaq - 9 days ago

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Zoetis Inc (Symbol: ZTS) entered into oversold territory, hitting an RSI reading of 29.8 ...See details»

2 Stocks to Buy Near Their 52-Week Lows

Source from : The Motley Fool - 8 days ago

Teladoc's effort to be profitable saw a major setback, but its opportunities remain vast. Zoetis' diversification and innovation are helping it navigate the challenging economy. Thankfully ...See details»

Monoclonal Antibodies In Veterinary Health Market Overview 2022 to 2030, Future Trends and Forecast | By -Zoetis, Merck & Co Inc, Elanco

Source from : MarketWatch - 11 days ago

The study examines the Monoclonal Antibodies In Veterinary Health market’s competitive landscape and includes data on important suppliers, including Zoetis, Merck & Co Inc, Elanco, Boehringer ...See details»

Veterinary Glucometers Scanner Market Set to Witness an Uptick Size US$ 336.2 Mn 2022 – 2032: Future Market Insights, Inc.

Source from : PharmiWeb - 4 days ago

The sales of veterinary glucometers market size is anticipated to grow at a CAGR of 5.1% through 2032. The global veterinary glucometers market size is currently valued at US$ 336.2 Mn in 2022 and is ...See details»

Zoetis Named a "100 Best Company" and a "Best Company for Dads" by Seramount

Source from : Stockhouse - 12 days ago